Disruption of cholesterol biosynthesis by Nsdhl knockout or statins treatment also induced SREBP1-dependent Tgfb1 expression and autocrine TGF-β-SMAD2/3 signaling in pancreatic cancer cells [43]. Here, SMAD2 is linked to familial pancreatic carcinoma.